MYCN is often ampli®ed in advanced-stage neuroblastomas with the consequence of enhanced MycN protein expression. By employing the yeast two-hybrid system we found that Yaf2 binds to the central region of MycN. Binding was also seen in vitro and in vivo. Ectopically expressed Yaf2, like MycN, is localized in the nuclei of neuroblastoma cells. Endogenous Yaf2 is expressed in all three tested neuroblastoma cell lines, all of which also express MycN. Yaf2 was able to enhance MycNmediated transactivation from an E-box promoter, deletion of the Yaf2 binding region in MycN abrogates this eect. Thus, the binding of Yaf2 to the central region of MycN is functional in mammalian cells. Oncogene (2001) 20, 5913 ± 5919.
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Members of the MYC gene family are often rearranged or ampli®ed in human and animal tumors (reviewed in Schwab, 1998; Schwab et al., 2000; Savelyeva and Schwab, 2001) . MYC, MYCN and MYCL all encode nuclear phosphoproteins that act as transcription factors. Common features are an N-terminal transcriptional transactivation domain and a C-terminal basic region (b) helix ± loop ± helix (HLH) leucine zipper (Zip). The basic region binds to the DNA sequence CAC GTG (E-box). The HLH-Zip motif mediates heterodimerization with Max, another bHLH-Zip protein.
Besides Max, several other proteins that interact with the C-terminal domain of Myc have been identi®ed including Yyl, Ap-2, Brcal, Miz-1 and Nmi (reviewed in Sakamuro and Prendergast, 1999) . The Nterminal domain interacts with p107, Bin1, Trrap, Mm-1, Amy-1, Pam, a-Tubulin (reviewed in Sakamuro and Prendergast, 1999) , Tip48 and Tip49 (Wood et al., 2000) . Max, Nmi, Trrap and Tip49 also bind to MycN (Bao and Zervos, 1996; Bannasch et al., 1999; Wood et al., 2000) .
Myc target genes are activated by the Myc/Max complex in an E-box dependent manner (reviewed in Henriksson and LuÈ scher, 1996; Dang, 1999) or are repressed by Myc through a mechanism that does not involve the Max protein (reviewed in Facchini and Penn, 1998; Claassen and Hann, 1999) . Among genes activated by Myc, such as cdc25A, a-prothymosin, ornithine decarboxylase (ODC) and telomerase reverse transcriptase (TERT) (reviewed in Dang, 1999) , aprothymosin, ODC and TERT are also activated by MycN (Lutz et al., 1996; MaÈ dge, unpublished observation) .
By employing the yeast two-hybrid system we here identify the Yaf2 protein as an additional MycN interaction partner. Yaf2 binds to a small central region in MycN. Binding was also detected in vitro and in vivo. Ectopically expressed Yaf2 protein, like MycN, localized in the nucleus of neuroblastoma cells. Endogenous Yaf2 was seen expressed in three of three tested neuroblastoma cell lines, all of which also express MycN. Yaf2 enhances transcriptional activation by MycN/Max from an E-box promoter, dependent on the presence of the central Yaf2 binding region in MycN. Thus, Yaf2 by interacting with the central region of MycN stimulates transcription.
In order to identify novel MycN interaction partners a yeast two-hybrid-screen (Fields and Song, 1989) was employed. A bait vector encoding a fusion protein of both the Gal4 DNA binding domain (Gal4 BD) and the central and C-terminal part of MycN (pGMYCN(177 ± 456)) was introduced into yeast HF7c cells. Resulting cells were transfected with an EBV-transformed B-cell cDNA library that encodes proteins fused to the Gal4 activation domain (Gal4 AD) (Durfee et al., 1993) . Screening of 1 million clones produced two coding for Max, 11 for Nmi and two for Yaf2. Max and Nmi were shown previously to interact both with Myc and MycN (Blackwood and Eisenman, 1991; Wenzel et al., 1991; Bao and Zervos, 1996; Bannasch et al., 1999) . Yaf2 was originally identi®ed as a binding partner of Yy1 (Kalenik et al., 1997) . One clone encoded full-length Yaf2 plus 10 additional amino acids in front of the start codon, derived from the N-terminal non-translated region of Yaf2 (pACT-YAF2). The other clone coded for a protein with an N-terminal truncation of 28 amino acids (pACT-YAF2(29 ± 180)). Interaction with MycN was con®rmed for both Yaf2 proteins by b-galactosidase (b-Gal) ®lter assays and by growth assays on SD/-trp/-leu/-his selection plates (lacking tryptophan, leucine and histidine) after transfection of isolated plasmids into HF7c yeast cells (Figure 1a and data not shown).
To determine if Yaf2 interacts with both MycN and Myc we used yeast two-hybrid b-Gal ®lter assays. Fulllength Yaf2 was used in combination with various bait proteins ( Figure 1a) . The central and C-terminal part The intensity of the blue color is a measure for the interaction strength: +++++, very strong; ++++, strong; +++, moderate; 7, not detectable. Methods: HF7c yeast (ClonTech) were transfected with pGMYCN(177 ± 456) which served as the bait. Cells were grown in SD/-trp medium lacking tryptophan and then transfected with a cDNA library from EBV-transformed B-cells (Durfee et al., 1993) . Transfectants were grown on SD/-trp/-leu/-his/ 3-AT selection plates lacking tryptophan, leucine and histidine and containing 3 mM 3-aminotriazol (3-AT). Colonies were picked and analysed for two-hybrid interaction by b-Gal ®lter assays (ClonTech protocol).`True' positives activated both reporter genes (HIS3 and lacZ) in HF7c. To con®rm the two-hybrid interaction bait and library plasmids were reintroduced into HF7c and growth as well as b-Gal ®lter assays were performed. Information about all plasmids used is available from the authors on request. The identity of all constructs was con®rmed by sequencing using an automated sequencer ABI PRISM 310 (Applied Biosystems). (b) Mapping of the binding region in MycN responsible for interaction with Yaf2. Interaction was determined by b-Gal ®lter-assays. Positive control was MycN(177 ± 456)/GAD-Max (not shown). Bait proteins are shown on the left. Legend for the b-Gal assays as in (a). pACT-YAF2 encoding full-length Yaf2 served as prey. Fusions of the Gal4BD to various MycN fragments were used as baits (left). Illustrations highlight functional domains of MycN: A, acidic region; N, nuclear localization signal; B, basic region; HLH, helix ± loop ± helix motif; Zip, leucine zipper. The ®rst and last amino acid of the protein fragments are indicated. The consensus MycN region mediating binding to Yaf2 is shown. Methods: pGBT9 (ClonTech) and pGBT9 derivates, encoding the bait proteins, were co-transfected with a prey vector (pACT-YAF2, pACT or pGAD-MAX) into yeast strain HF7c (ClonTech) and grown at 308C on SD/-trp/-leu selection plates lacking tryptophan and leucine as well as on SD/-trp/-leu/-his selection plates additionally lacking histidine. Growth on SD/-trp/-leu/-his plates indicated that the HIS3 reporter gene in HF7c had been activated as the result of speci®c interaction between bait and prey protein (growth assay). Colonies were picked and incubated for 2 days in SD/-trp/-leu medium at 308C and 175 r.p.m. Subsequently 5 ml of these cultures were spotted regularly on ®lters (Whatman No. 1) which had been laid on fresh SD/-trp/-leu plates. After incubation for 2 days at 308C ®lters were lifted from the plates, and b-galactosidase (bGal) ®lter assays were performed (ClonTech protocol). Color reactions were stopped after 3 ± 6 h. The combination pGMYCN(177 ± 456)/pGAD-MAX represents the well studied interaction of MycN and Max (Wenzel et al., 1991; Bannasch and Schwab, 1999) and served as positive control in all b-Gal assays Figure 1a ). In contrast, the central and C-terminal part of Myc (Myc(180 ± 439)) failed to functionally interact ( Figure 1a ). Neither the Gal4 DNA binding domain alone (Gal4 BD), nor fusions of the Gal4 BD with p53 (p53 (72 ± 370)) or with Max (Max (2 ± 160)), which served as negative controls did interact with Yaf2 ( Figure 1a ). All interactions were con®rmed by growth assays on SD/-trp/-leu/-his selection plates (data not shown). Taken In order to ®nd out if Yaf2 binds to MycN in vitro, we performed GST-pull-down assays. Equal amounts of GST, GST-Max and GST-Yaf2 were bound to glutathione-sepharose beads that were subsequently incubated with in vitro translated radio-labeled MycN. MycN bound both to immobilized GST-Yaf2 and GST-Max (positive control), but not to GST alone (Figure 2a, lanes 1 ± 3) . Less MycN was bound to Yaf2, as compared to Max, indicating that the MycN/Yaf2 interaction in vitro is weaker than the MycN/Max binding. A deletion mutant lacking aa 267 ± 298 of MycN (D31MycN) bound only very weakly to Yaf2 (Figure 2a, lane 7) . In contrast, the interactions of D31MycN and of MycN to Max were similar (Figure 2a , compare lanes 6 and 2). Thus, like in the yeast two-hybrid assay a small central region of MycN (aa 267 ± 298) is essential for MycN/Yaf2 interaction in vitro. The binding region contains at its N-terminus the four C-terminal amino acids (aa 267 ± 270) of the acidic region (aa 257 ± 270), which is conserved in part also in Myc. As most part of the binding region is located directly Cterminal to the acidic region, the acidic region itself is not likely to be important for MycN binding to Yaf2.
In contrast to Max, which associates with the HLHZip motif of MycN, both Yaf2 and Nmi bind to a central region of MycN (this study; Bannasch et al., 1999) . The MycN region responsible for interaction with Yaf2 is much smaller compared to the MycN portion involved in binding to Nmi (Bannasch et al., 1999) . As these two binding regions overlap, but are not identical, it seems likely that dierent structures of the MycN protein mediate binding to Yaf2 and to Nmi.
In order to detect MycN/Yaf2 complexes in vivo, we performed in vivo GST pull-down assays. MycN was co-expressed together with either GST-Yaf2, GST-Max (postive control) or GST (negative control) in transiently transfected 293 cells. After lysis of cells the GST fusion proteins were immobilized on glutathione sepharose beads. Bound proteins were separated by SDS ± PAGE and analysed by immunoblotting (Figure 2b ). MycN bound to both Yaf2 and Max in vivo (Figure 2b, left panel) . Again, the MycN/ Yaf2 anity was weaker than the MycN/Max anity, similar to the results obtained in vitro. This could explain our failure to detect Yaf2/MycN complexes by co-immunoprecipitation, even under conditions of low stringency (data not shown). In contrast, heterodimers of endogenous Max and MycN were easily detected by co-immunoprecipitation (data not shown). We conclude that MycN and Yaf2 interact in vivo and that the MycN/Yaf2 interaction is less stable than the MycN/ Max interaction.
By Western blotting we found Yaf2 protein expression in three neuroblastoma cell lines (Kelly, IMR-32, IMR5-75) (Figure 2c, lower panel, lanes 1 ± 3) , all of which also express MycN (Figure 2c , upper panel, lanes 1 ± 3). However, there seems to be no correlation of the MycN and Yaf2 expression level. While the level of MycN in the three cell lines was similar, the amount of Yaf2 in IMR5-75 was much lower than in the two other cell lines. In GI-ME-N neuroblastoma cells, which have no detectable MycN, (Figure 2c Furthermore, Yaf2 is expressed in HeLa, COLO-320-HSR and, at low level, in 293 embryonic kidney cells (Figure 2c , lower panel, lanes 5 ± 7), demonstrating that Yaf2 has a more broad expression range than MycN. Yaf2 protein migrates as a band of 26 kD in a protein gel (SDS ± PAGE). This was con®rmed by ectopically expressing Yaf2 in pU-YAF2 transfected 293 cells (lower panel, lane 8).
The subcellular localization of Yaf2 was determined by¯uorescence microscopy. EGFP-Yaf2, a fusion of the enhanced green¯uorescent protein (EGFP) and Yaf2, or EGFP alone (control) was transiently expressed in Kelly neuroblastoma cells, which have large amount of MycN. Cells expressing EGFP revealed both a nuclear and cytoplasmic staining (Figure 3c ). In contrast, cells expressing EGFP-Yaf2 showed exclusively nuclear staining (Figure 3g ). DAPIstain of nuclei served as the control (Figure 3a S-methionine labeled, in vitro translated MycN (lanes 1 ± 3) or D31MycN (lanes 5 ± 7). Bound proteins were separated by SDS ± PAGE and detected by¯uorography.`Input' represents 10% of the total amount of in vitro translated proteins used in each assay (lanes 4 and 8). Methods: GST, GST-Max and GST-Yaf2 fusion proteins were expressed in bacteria and puri®ed after lysis of the bacteria using glutathione-sepharose 4B beads (Pharmacia). Thirty ml beads, loaded with 10 mg of GST or GST fusion protein, were incubated with L-35 S-methionine labeled in vitro translated full-length or mutant MycN protein (encoded by pSPA-MYCN or pD31MYCN respectively) in 400 ml association buer (50 mM Tris/HCl, pH 8.0; 100 mM NaCl; 1 mM EDTA; 0.5% NP 40 (Sigma); 20 ml of a stock-solution of a protease-inhibitor cocktail (Complete, Roche)) at 48C for 1.5 ± 2 h with gentle agitation. Then, beads were washed ®ve times with association buer. Subsequently, samples were boiled for 5 min in 100 ml 16SDS-sample buer. Proteins were resolved by SDS-polyacrylamide gel electrophoresis (SDS ± PAGE) and bound MycN proteins were detected by¯uorography. (b) In vivo GST pull-down assay. Human kidney 293 cells were transiently transfected with two plasmids: the ®rst expressing MycN, the second expressing either GST, GST-Max or GST-Yaf2. Thirty-six hours after transfection cells were lysed and cell extracts were incubated with glutathione-sepharose beads. Bound proteins were separated by SDS ± PAGE and analysed by Western blotting. MycN was detected by anti-MycN antibodies (B8.4.B; Pharmingen) (left panel). As a control the blot was stripped and subsequently re-probed with polyclonal anti-GST antibodies (Ab-1; Calbiochem) (right panel). Methods: 293 cells were grown in RPMI medium containing 12% FCS, 100 units/ml penicillin, 100 mg/ ml streptomycin and 0.2% amphotericin. The cells were transiently transfected using standard calcium phosphate method for 36 h with pCMV-GST (Tsai and Reed, 1997) , pCMV-GST-Max or pCMV-GST-YAF2, respectively. In vivo GST pull-down assays were performed as described (Chatton et al., 1995; GarcõÂ a et al., 1999) . Brie¯y, 80 ml of cell extract was mixed with 20 ml of glutathione sepharose-beads. Consequent to incubation for 1 h at 48C under continuous rotation beads were washed in lysis buer four times. Proteins were eluted in Laemmli buer, separated by SDS ± PAGE and analysed by Western blot. 7) as well as of pU-YAF2 transfected 293 cells (lane 8) which served as a control were separated via SDS ± PAGE and subjected to Western blotting. Yaf2 proteins were detected with Yaf2 antiserum YA34/2 (lower panel). As control we used pre-immune serum (data not shown). MycN proteins were detected with anti-MycN antibodies (B8.4.B; Pharmingen) (upper panel). The size of the marker proteins is indicated (left). Methods: Cell lines were grown in RPMI medium containing 12% FCS, 100 units/ml penicillin, 100 mg/ml streptomycin and 0.2% amphotericin. Cells were grown at 378C, 5% CO 2 . For detection of endogenous or ectopically detected the MycN protein exclusively in the nuclei by using monoclonal anti-MycN antibodies (Wenzel et al., 1991; Figure 3b,f) . Ectopically expressed Yaf2 and MycN are both nuclear in the same pEGFP-YAF2 transfected Kelly cells (Figure 3g,h) . Thus, Yaf2, like MycN, is a nuclear protein.
To ®nd out if Yaf2 is capable of regulating MycNmediated transactivation we performed reporter gene assays. NIH3T3 cells were transfected with a 46E-box-luciferase reporter plasmid (46E-box-luc) and with various eector plasmids encoding MycN, Max and Yaf2, respectively. To correct luciferase values for variations due to transfection eciency, cells were cotransfected with CMV-b-Gal and luciferase raw data were normalized against b-Gal units. Transfections were performed in triplicate and repeated three times. Reporter gene activation was determined by relating luciferase levels of transfections with eector plasmids to those of empty vector (Figure 4 ). With this group of nine results we carried out an analysis of variance, applying a two-way layout using experiment (day) and treatment as experimental factors. In Figure 4 the least squares means of each group are shown, the error bars represent a 95% con®dence interval for the true means with regard to the treatment experimental factor.
MycN alone activated 2.4-fold (Figure 4 , ®rst bar). Co-expression of MycN and Max resulted in a 3.8-fold activation, additional co-expression of Yaf2 elevated the expression to approximately sixfold (2nd and 3rd bar). No activation was detected in the presence of Yaf2 alone (Figure 4) . Principally similar results were obtained by using either a-prothymosin-or ornithine decarboxylase (ODC) promotor ± reporter constructs that were transiently transfected in neuroblastoma cells which carry two stably transfected genes, a constitutively expressed YAF2 gene and an inducible MYCN gene (MaÈ dge, manuscript in preparation). Transfection of MycN deletion mutant D31MycN resulted in promotor activation; this activation was enhanced signi®cantly by Max cotransfection (Figure 4 , 4th and 5th bar). Additional expression of Yaf2 did not aect reporter gene activity (6th bar), demonstrating that Yaf2 in¯uence on MycN depends on the central binding region in MycN. Yaf2 alone showed no expressed proteins cells were lysed in DS-lysis buer (50 mM Tris/HCl, pH 8.0; 50 mM NaCl; 1 mM EDTA; 0.5% NP 40 (Sigma); 0.5% deoxycholate, 0.5% SDS and 1/25 vol of a stock-solution of a protease-inhibitor cocktail (Complete, Roche)), sonicated and cell debris was removed by centrifugation. Lysates were mixed with Laemmli buer and proteins were separated by SDS ± PAGE, transferred to PVDF membranes (Amersham) which subsequently were incubated in blocking buer (PBS containing 20% non-fat milk powder, 20% FCS, 3% BSA, 1% goat normal serum, 0.2% Tween 20) over-night at 48C. Then ®lters were incubated with antiMycN antibody (0.2 ± 1 mg/ml in blocking buer) or Yaf2 antiserum YA34/2 (polyclonal rabbit Yaf2 antiserum, raised against a Cterminal peptide of Yaf2; diluted 1 : 7500 in blocking buer) for 1 ± 2 h at 48C. Filters were washed four times with PBS-T (PBS, 0.2% Tween 20), incubated with horseradish peroxidase conjugated goat anti-mouse or goat-anti rabbit IgG (Dianova, diluted 1 : 1000 in blocking buer) for 1 h at room temperature, washed as above and developed using an enhanced chemiluminescence reaction kit (ECL, Amersham). Preimmune serum served as control for the speci®city of the Yaf2 antiserum (data not shown) Immuno¯uorescence was performed as described (Bannasch et al., 1999) . Brie¯y, cells were grown on poly-lysine coated cover-slips in RPMI medium at 378C, 5% CO 2 until they had reached 50 ± 80% con¯uence. Then cells were transfected with 0.4 mg of plasmid DNA using Eectene transfection kit (Qiagen) After incubation for 24 ± 36 h under tissue culture conditions cells were washed, ®xed in 3.7% formaldehyde in PBS and permeabilized in PBS containing 0.05% Nonidet P40 (Sigma) and 0.1% BSA. MycN was detected using monoclonal anti-MycN antibody B8.4.B (Pharmingen) in¯uence on the 46E-box promoter. Taken together, Yaf2 enhances MycN-mediated reporter gene activation; deletion of the Yaf2 binding region in MycN abrogates this eect. In an analogous way the Myc interaction partner Amy-1 stimulates activation of Ebox-regulated transcription by the Myc/Max complex (Taira et al., 1998) .
As a nuclear protein Yaf2 is likely to be involved in nuclear processes, such as activation or repression of transcription. As Yaf2 binds to a central region and Max to a C-terminal part of MycN it is possible that Yaf2 and Max interact simultaneously with MycN. A possible role for Yaf2 could be to act in ®ne-tuning the connection of the MycN/Max complex to the transcription machinery, thereby modulating the activity of the MycN/Max complex in transcriptional activation of potential MycN target genes. Although co-immunoprecipitation did neither provide evidence for a MycN/Yaf2 complex nor for a ternary complex of MycN, Max and Yaf2 (data not shown), Yaf2, in the presence of Max, can enhance MycN mediated transcription of E-box containing reporter genes ± among them two known MycN target genes, aprothymosin and ODC (Lutz et al., 1996) Mammalian Yy1 which is considered to be related to the Drosophila polycomb protein pleiohomeotic (Brown et al., 1998) has been shown to interact with Myc in vivo (Shrivastava et al., 1996) as well as with Yaf2 in vitro (Kalenik et al., 1997) . Therefore both Myc and Yaf2 could play a role in chromatin remodeling complexes. In order to ®nd out if MycN could be linked to chromatin remodeling, we performed co-immunoprecipitation experiments under conditions of low stringency on lysates of Kelly neuroblastoma cells. No interaction of MycN and Yy1 was detected, in contrast to complexes of MycN/ Max that were easily demonstrated (data not shown).
Rybp, which is closely related to Yaf2, is ± similar to Yaf2 ± capable of interacting with Yy1 (GarcõÂ a et al., 1999). Furthermore, it also binds to RING1A and RINGIB, which are involved in silencing developmentally relevant genes (GarcõÂ a et al., 1999). As MycN is able to bind to Rybp in vitro (MaÈ dge, unpublished observation), MycN could be involved in chromatin remodeling processes. Supposed, that both Yaf2 and Rybp play a role in silencing of developmentally relevant genes, binding of MycN to Yaf2 or to Rybp could discriminate between genes to be silenced.
The results presented here demonstrate that Yaf2 binds to MycN in vitro and in vivo and that Yaf2 is likely to act as a positive modulator of transactivation mediated by the MycN/Max complex. Figure 4 Yaf2 enhances MycN-mediated transcriptional activation. NIH3T3 cells were transfected with a 46E-box-luciferase reporter plasmid and additionally with expression vectors encoding MycN, D31MycN, Max or Yaf2. The basal luciferase activity that was achieved by cotransfection of reporter plasmid and empty expression vector was de®ned as onefold activation. Results of three independent experiments that were done in triplicate are shown. Statistical evalutation is described in the text. Methods: NIH3T3 cells were grown in DMEM medium (Gibco ± BRL), 10% FCS containing 100 units/ml penicillin, 100 mg/ml streptomycin and 0.2% amphotericin. Cells were seeded at a density of 5610 4 cells per well in 12 well plates and transfected with 800 ng DNA (using Eectene transfection kit (Qiagen)). For reporter gene assays 100 ng of each reporter plasmid, 46E-boxluciferase and pCMV-b-galactosidase were used together with 150 ng of each eector plasmid, pCMV-MYCN, pCMV-D31MYCN, pCMV-MAX, pCMV-YAF2 or the according empty vector. Cells were incubated 36 ± 48 h at 378C, 5% CO 2 to allow ectopic protein expression. Luciferase and galactosidase activities were measured using the Dual Light Kit (Tropix) and an appropriate Luminometer. Luciferase units were normalized against b-galactosidase units 
